Apg Asset Management N.V. Myriad Genetics Inc Transaction History

Apg Asset Management N.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$37.57 - $50.34 $510,952 - $684,624	-13,600 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$27.75 - $40.17 $2.24 Million - $3.24 Million	-80,600 Reduced 85.56%	13,600 $435,000
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $302,715 - $430,605	-10,500 Reduced 10.03%	94,200 $2.26 Million
Q4 2017 Jan 24, 2018	BUY	$28.45 - $37.14 $2.98 Million - $3.89 Million	104,700	104,700 $3 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.27B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.